Patents by Inventor Inna Reiner

Inna Reiner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic apoptotic cell preparations, method for producing same and uses thereof
    Patent number: 10927343
    Abstract: The present application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state, methods for the production of said compositions and uses thereof in the treatment of diseases characterized by pathological immune responses. The pharmaceutical compositions may be used in treatment of conditions such as, but not limited to, graft versus host disease (GVHD) and autoimmune diseases including but not limited to inflammatory bowel disease, gout and arthritis.
    Type: Grant
    Filed: July 29, 2018
    Date of Patent: February 23, 2021
    Assignee: ENLIVEX THERAPEUTICS LTD
    Inventors: Dror Mevorach, Inna Reiner
  • THERAPEUTIC APOPTOTIC CELL PREPARATIONS, METHOD FOR PRODUCING SAME AND USES THEREOF
    Publication number: 20190024048
    Abstract: The present application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state, methods for the production of said compositions and uses thereof in the treatment of diseases characterized by pathological immune responses. The pharmaceutical compositions may be used in treatment of conditions such as, but not limited to, graft versus host disease (GVHD) and autoimmune diseases including but not limited to inflammatory bowel disease, gout and arthritis.
    Type: Application
    Filed: July 29, 2018
    Publication date: January 24, 2019
    Applicant: ENLIVEX THERAPEUTICS LTD
    Inventors: Dror MEVORACH, Inna Reiner
  • Therapeutic apoptotic cell preparations, method for producing same and uses thereof
    Patent number: 10077426
    Abstract: The present application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state, methods for the production of said compositions and uses thereof in the treatment of diseases characterized by pathological immune responses. The pharmaceutical compositions may be used in treatment of conditions such as, but not limited to, graft versus host disease (GVHD) and autoimmune diseases including but not limited to inflammatory bowel disease, gout and arthritis.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: September 18, 2018
    Assignee: Enlivex Therapeutics Ltd
    Inventors: Dror Mevorach, Inna Reiner
  • THERAPEUTIC APOPTOTIC CELL PREPARATIONS, METHOD FOR PRODUCING SAME AND USES THEREOF
    Publication number: 20150275175
    Abstract: The present application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state, methods for the production of said compositions and uses thereof in the treatment of diseases characterized by pathological immune responses. The pharmaceutical compositions may be used in treatment of conditions such as, but not limited to, graft versus host disease (GVHD) and autoimmune diseases including but not limited to inflammatory bowel disease, gout and arthritis.
    Type: Application
    Filed: December 5, 2013
    Publication date: October 1, 2015
    Inventors: Dror Mevorach, Inna Reiner